Espace Murger, Hôpital Fernand Widal
Paris, 75010, France
NCT Number: NCT01569347
The aim of this study is to determine the clinical, genetic and environmental factors associated with the phenotype "severe psychotic symptoms" caused by cocaine.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75010, France
The second purpose is to include gene x environment interaction and to analyse the factors associated with the presence or the absence of severe psychotic symptoms induced by cocaine.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interviews
Blood sample
Hair sample
Time frame: up to one day after taking cocaine
Time frame: up to one day after taking cocaine
clinical and genetic data
Assistance Publique - Hôpitaux de Paris
Other
Multicentric Descriptive Cross-sectional Study Evaluating Cocaine Users in Treatment Center
Acronym: PSYCHOCOKE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.